All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @februerin on TikTok · 98s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @februerin's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Hi there. I'm diabetic. I have type 2 diabetes and I manage that with medication including
  2. 0:09Ozempic. And I kind of wanted to show everybody how I take my Ozempic every single week. So
  3. 0:19I'm currently on the 1 milligram dose so there's only one measurement in the pen. So I take
  4. 0:24the little capsule here which contains my needle inside. Take the pen, take the cap off.
  5. 0:31This is the old needle. I just screw this off and just throw away. And then take the pen
  6. 0:38with the new cap and then just twist it on like so. Make sure it's a little bit tight.
  7. 0:45Take the outer cap off so now I have a new needle and I have the medicine in the pen ready
  8. 0:50to go. So then I've got this little counter here. I will twist this until it stops at the
  9. 0:57one and then take this little inner cap off so that I can see the needle inside. And then
  10. 1:05I inject my Ozempic on my stomach and so I will just take the needle. You can kind of
  11. 1:14barely see it there. And I will just stabby stabby. And that's it. And that's how I take
  12. 1:27my Ozempic every single week. I hope this helps anybody who is new to this particular medication
  13. 1:33or new to this particular medication delivery system. Thanks.

Ozempic first-timer tips: what TikTok gets right and wrong

FebruErin

TikTok creator

447.9K viewsWatch on TikTok

Quick answer

Semaglutide (Ozempic) is an FDA-approved GLP-1 receptor agonist administered once weekly via subcutaneous injection, indicated for glycemic control in adults with type 2 diabetes. The 1 mg dose the creator references is an approved maintenance dose per the Ozempic prescribing information, reached after a titration period starting at 0.25 mg. Correct pen technique, including priming before first use and site rotation, affects both safety and drug delivery consistency.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Ozempic first-timer tips: what TikTok gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Compounded Semaglutide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Ozempic first-timer tips: what TikTok gets right and wrong" from FebruErin. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Semaglutide (Ozempic) is an FDA-approved GLP-1 receptor agonist administered once weekly via subcutaneous injection, indicated for glycemic control in adults with type 2 diabetes.

The reason this review is not generic is the source wording and the canonical claim label "glp1 take a shot every time i say um anyway hope this helps anyon." In this clip, the useful excerpt is: "Hi there." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The abdomen is a valid injection site, but rotating between sites matters: Frid et al.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Semaglutide (Ozempic) is an FDA-approved GLP-1 receptor agonist administered once weekly via subcutaneous injection, indicated for glycemic control in adults with type 2 diabetes.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Semaglutide (Ozempic) is an FDA-approved GLP-1 receptor agonist administered once weekly via subcutaneous injection, indicated for glycemic control in adults with type 2 diabetes. The 1 mg dose the creator references is an approved maintenance dose per the Ozempic prescribing information, reached after a titration period starting at 0.25 mg. Correct pen technique, including priming before first use and site rotation, affects both safety and drug delivery consistency.
  • The Ozempic 1 mg weekly dose shown is FDA-approved for type 2 diabetes; SUSTAIN trials (Marso et al., 2016, NEJM) established its efficacy and safety profile.
  • The abdomen is a valid injection site, but rotating between sites matters: Frid et al. (2016, Diabetes & Metabolism) found repeated use of the same spot causes lipohypertrophy that impairs drug absorption.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • The Ozempic 1 mg weekly dose shown is FDA-approved for type 2 diabetes; SUSTAIN trials (Marso et al., 2016, NEJM) established its efficacy and safety profile.
  • The abdomen is a valid injection site, but rotating between sites matters: Frid et al. (2016, Diabetes & Metabolism) found repeated use of the same spot causes lipohypertrophy that impairs drug absorption.
  • New Ozempic pen users must perform a priming flow check before first use per Novo Nordisk instructions. This step was not shown in the video.
  • Used insulin and GLP-1 needles are regulated medical sharps. The FDA and CDC require disposal in approved sharps containers, not household trash. The video does not address this.
  • In-use Ozempic pens can be stored at room temperature (up to 77 degrees F) for 56 days per the prescribing information. Unopened pens require refrigeration.
  • Personal experience videos for injectable prescription medications have real value for reducing injection anxiety, but should be supplemented with manufacturer instructions or pharmacist guidance, not used as a standalone reference.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @februerin actually say?

This is a straightforward how-to video from someone managing type 2 diabetes with semaglutide (Ozempic). The creator walks through attaching a new needle, dialing to the correct dose, removing the inner cap, and injecting into the stomach. She describes being on "the 1 milligram dose" and says there's "only one measurement in the pen." No dramatic health claims, no miracle cures. Just a person showing how they do their weekly injection.

The video has nearly 450,000 views, which means a lot of people new to injectable GLP-1 medications are probably watching this as a reference. That makes accuracy matter more than usual. Most of what she demonstrates is reasonable. A few things are worth examining more closely.

Does the science back this up?

The core administration steps she shows are consistent with Novo Nordisk's prescribing information and clinical guidance. Subcutaneous injection into the abdomen is one of three approved injection sites for semaglutide, alongside the thigh and upper arm. The FDA-approved label and a 2021 review by Christou et al. in Diabetes Therapy confirm that rotating injection sites reduces localized lipohypertrophy, something she doesn't mention but also doesn't contradict.

The SUSTAIN clinical trials, which supported Ozempic's approval, used once-weekly subcutaneous dosing. The 1 mg maintenance dose she references is a legitimate approved dose for type 2 diabetes management. The pen device she's using, the FlexTouch-style Ozempic pen, does work the way she describes: dial, cap off, inject. Her mechanical description is accurate enough that it wouldn't lead someone badly astray.

What did they get wrong (or right)?

She got the basics right. The needle attachment, cap removal sequence, and injection site are all defensible. Credit where it's due.

But there are a few gaps worth naming. First, she says there's "only one measurement in the pen" at the 1 mg dose. That's technically true for the 1 mg/dose pen, but it could confuse viewers who are titrating up from 0.25 mg or 0.5 mg, where the same pen style has different dial stops. The comment implies all Ozempic pens work identically, which isn't quite right.

Second, and more importantly, she doesn't mention priming the pen before the first use. Novo Nordisk's instructions specify a flow check (priming step) before initial use to ensure the pen is working correctly. Skipping this step can result in underdosing. This is a real omission for a tutorial aimed at people who are new to the medication.

Third, there's no mention of safe needle disposal. Used needles should go into a sharps container, not the general trash. The CDC and FDA both flag improper sharps disposal as a public health issue.

What should you actually know?

If you're starting Ozempic, the injection mechanics are learnable and not that intimidating. That part of the video is reassuring and mostly accurate. But a few things matter that didn't make the cut here.

  • Always prime the pen before first use. The Novo Nordisk FlexTouch instructions walk through this step specifically.
  • Rotate your injection sites. Using the same spot repeatedly causes tissue changes that affect drug absorption, per guidance summarized in Frid et al. (2016, Diabetes & Metabolism).
  • Use a proper sharps disposal container. Many pharmacies offer them, and some states have mail-back programs.
  • Store your pen correctly. Unopened pens go in the refrigerator. Once in use, the pen can be kept at room temperature for up to 56 days according to the prescribing information.

None of this makes @februerin's video dangerous. It makes it incomplete. For 450,000 viewers, incomplete is worth filling in.

Is this video safe to follow?

Mostly, yes, with caveats. The injection technique won't hurt anyone. The omissions (no pen priming, no sharps disposal, no rotation guidance) are real but not catastrophic for someone who also reads the patient information leaflet that comes with the medication. The problem is that a lot of people won't read the leaflet. They'll watch this video instead.

The creator is sharing her personal experience in good faith, and that has real value for reducing injection anxiety. But personal experience tutorials for prescription injectables have a higher bar than, say, a recipe video. If you're using this as your primary reference, supplement it with the actual manufacturer instructions or ask your pharmacist to walk you through it in person.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

FebruErin · TikTok creator

447.9K views on this video

Take a shot every time i say “um” 🤣 Anyway, hope this helps anyone else new to Ozempic! #diabetic #type2diabetes #type2 #diabetesawareness #diabetes #fyp #fypシ #medicine

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the ozempic 1 mg weekly dose shown?

The Ozempic 1 mg weekly dose shown is FDA-approved for type 2 diabetes; SUSTAIN trials (Marso et al., 2016, NEJM) established its efficacy and safety profile.

What does the video say about the abdomen?

The abdomen is a valid injection site, but rotating between sites matters: Frid et al. (2016, Diabetes & Metabolism) found repeated use of the same spot causes lipohypertrophy that impairs drug absorption.

What does the video say about new ozempic pen users must perform a priming flow check?

New Ozempic pen users must perform a priming flow check before first use per Novo Nordisk instructions. This step was not shown in the video.

What does the video say about used insulin?

Used insulin and GLP-1 needles are regulated medical sharps. The FDA and CDC require disposal in approved sharps containers, not household trash. The video does not address this.

What does the video say about in-use ozempic pens can be stored at room temperature (up?

In-use Ozempic pens can be stored at room temperature (up to 77 degrees F) for 56 days per the prescribing information. Unopened pens require refrigeration.

What does the video say about personal experience videos for injectable prescription medications have real value?

Personal experience videos for injectable prescription medications have real value for reducing injection anxiety, but should be supplemented with manufacturer instructions or pharmacist guidance, not used as a standalone reference.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by FebruErin, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.